Cargando…
The PCSK9 discovery, an inactive protease with varied functions in hypercholesterolemia, viral infections, and cancer
In 2003, the sequences of mammalian proprotein convertase subtilisin/kexin type 9 (PCSK9) were reported. Radiolabeling pulse-chase analyses demonstrated that PCSK9 was synthesized as a precursor (proPCSK9) that undergoes autocatalytic cleavage in the endoplasmic reticulum into PCSK9, which is then s...
Autor principal: | Seidah, Nabil G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551645/ https://www.ncbi.nlm.nih.gov/pubmed/34606887 http://dx.doi.org/10.1016/j.jlr.2021.100130 |
Ejemplares similares
-
The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017) -
Lipoprotein metabolism in familial hypercholesterolemia
por: Chemello, Kévin, et al.
Publicado: (2021) -
Existing and emerging therapies for the treatment of familial hypercholesterolemia
por: Rosenson, Robert S.
Publicado: (2021) -
Genetic testing for familial hypercholesterolemia—past, present, and future
por: Futema, Marta, et al.
Publicado: (2021) -
The Multifaceted Biology of PCSK9
por: Seidah, Nabil G, et al.
Publicado: (2021)